Discover

BVS
Bioventus Inc.
13.85
1 x 13.84
1 x 13.86
bid
ask
-
0.11
0.77%
12:35 PM
timesize
Ytd86.19%
1y99.90%
13.71
day range
13.97
6.25
52 week range
15.89
Open13.71Prev Close13.96Low13.71High13.97Mkt Cap938.58M
Vol163.97KAvg Vol757.65KEPS0.76P/E18.23Forward P/E13.08
Beta0.63Short Ratio3.11Inst. Own78.24%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg10.87200-d Avg9.051yr Est14.80

BVS News

Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy
benzinga.com
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Ban

Major M&A deals include Visa buys BioCatch, Apollo Global nabs EasyJet, QVC emerges from Chapter

Is Bioventus (BVS) Stock Undervalued Right Now?
zacks.com
Is Bioventus (BVS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Bioventus Inc. (BVS) Q2 2026 Earnings Call Transcript
seekingalpha.com
Bioventus Inc. (BVS) Q2 2026 Earnings Call Transcript

Bioventus Inc. (BVS) Q2 2026 Earnings Call Transcript

Bioventus Q2 Earnings Call Highlights
marketbeat.com
Bioventus Q2 Earnings Call Highlights

Bioventus NASDAQ: BVS reported second-quarter 2026 revenue growth of 4% and reiterated its full-year

Bioventus (BVS) Q2 Earnings Meet Estimates
zacks.com
Bioventus (BVS) Q2 Earnings Meet Estimates

Bioventus (BVS) came out with quarterly earnings of $0.22 per share, in line with the Zacks Consensu

benzinga.com
Bioventus Q2 Adj. EPS $0.22, Inline, Sales $153.208M Miss $155.640M Estimate

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.22 per share which met the analyst consensu

benzinga.com
Bioventus Affirms FY2026 Adj EPS Guidance of $0.75-$0.79 vs $0.78 Est; Affirms FY2026 Sales Guidance

Bioventus (NASDAQ:BVS) affirms FY2026 Adj EPS guidance from $0.75-$0.79 to $0.75-$0.79 vs $0.78 anal

Bioventus Reports Second Quarter Financial Results
globenewswire.com
Bioventus Reports Second Quarter Financial Results

DURHAM, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Co

5 Growth Stocks That Pass Peter Lynch's Favorite Test
benzinga.com
5 Growth Stocks That Pass Peter Lynch's Favorite Test

Wall Street loves to make stock selection sound like a combination of advanced calculus, artificial

Under the Radar: 3 Boring Small Caps That Could Return 10x
benzinga.com
Under the Radar: 3 Boring Small Caps That Could Return 10x

Investors spend an enormous amount of time searching for the next stock that can rise 10 times in va

Bioventus (BVS) to Report Q2 Results: Wall Street Expects Earnings Growth
zacks.com
Bioventus (BVS) to Report Q2 Results: Wall Street Expects Earnings Growth

Bioventus (BVS) doesn't possess the right combination of the two key ingredients for a likely earnin

Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
globenewswire.com
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026

DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Co

Is Bioventus (BVS) Stock Outpacing Its Medical Peers This Year?
zacks.com
Is Bioventus (BVS) Stock Outpacing Its Medical Peers This Year?

Here is how Bioventus (BVS) and Aveanna Healthcare (AVAH) have performed compared to their sector so

Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket

Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans

Does Bioventus (BVS) Have the Potential to Rally 28.92% as Wall Street Analysts Expect?
zacks.com
Does Bioventus (BVS) Have the Potential to Rally 28.92% as Wall Street Analysts Expect?

The consensus price target hints at a 28.9% upside potential for Bioventus (BVS). While empirical re

Bioventus (BVS) Upgraded to Buy: Here's Why
zacks.com
Bioventus (BVS) Upgraded to Buy: Here's Why

Bioventus (BVS) might move higher on growing optimism about its earnings prospects, which is reflect

Should Value Investors Buy Bioventus (BVS) Stock?
zacks.com
Should Value Investors Buy Bioventus (BVS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice
zacks.com
Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice

Does Bioventus (BVS) have what it takes to be a top stock pick for momentum investors? Let's find ou

Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know
zacks.com
Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know

The mean of analysts' price targets for Bioventus (BVS) points to a 28.8% upside in the stock. While

Bioventus: I See A Better Business Trading At A Fair Price (Upgrade)
seekingalpha.com
Bioventus: I See A Better Business Trading At A Fair Price (Upgrade)

Bioventus Inc. develops medical devices and biologics for orthopedic recovery and pain relief. I pre

Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?
zacks.com
Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?

Bioventus (BVS) was a big mover last session on higher-than-average trading volume. The latest trend

Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market

3 Top Breakout Stocks to Snap Up for Big Upside in July 2026
zacks.com
3 Top Breakout Stocks to Snap Up for Big Upside in July 2026

FA, BVS and OOMA emerged as July breakout stock picks after meeting momentum and price-based screens

Should Value Investors Buy Bioventus (BVS) Stock?
zacks.com
Should Value Investors Buy Bioventus (BVS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Are Investors Undervaluing Bioventus (BVS) Right Now?
zacks.com
Are Investors Undervaluing Bioventus (BVS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls
marketbeat.com
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls

Bioventus NASDAQ: BVS executives outlined the company's portfolio strategy, growth priorities and ca

Transcript: Bioventus Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Bioventus Q1 2026 Earnings Conference Call

benzinga.com
Bioventus Says FDA Reclassifies Exogen Ultrasound Bone Healing System To Class II Device On April 16

On April 16, 2026, the U.S. Food and Drug Administration ("FDA") issued a final order reclas

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

benzinga.com
Bioventus Raises FY2026 Adj EPS Guidance from $0.73-$0.77 to $0.75-$0.79 vs $0.75 Est; Affirms FY202

Bioventus (NASDAQ:BVS) raises FY2026 Adj EPS guidance from $0.73-$0.77 to $0.75-$0.79 vs $0.75 analy

benzinga.com
Bioventus Q1 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $132.089M Beat $129.850M Estimate

Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.15 per share which beat the analyst consens

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Barrington Research Maintains Outperform on Bioventus, Raises Price Target to $14

Barrington Research analyst Michael Petusky maintains Bioventus (NASDAQ:BVS) with a Outperform an

benzinga.com
Craig-Hallum Maintains Buy on Bioventus, Raises Price Target to $16

Craig-Hallum analyst Alexander Nowak maintains Bioventus (NASDAQ:BVS) with a Buy and raises the p

Bioventus Q4 Earnings Assessment
benzinga.com
Bioventus Q4 Earnings Assessment

Bioventus Earnings Report: Q4 Overview
benzinga.com
Bioventus Earnings Report: Q4 Overview

benzinga.com
Bioventus Sees FY2026 Adj EPS $0.73-$0.77 vs $0.77 Est; Sees Sales $600.000M-$610.000M vs $604.182M

2026 Financial Guidance Bioventus introduced its financial guidance for full-year 2026. The Company

Earnings Scheduled For March 5, 2026
benzinga.com
Earnings Scheduled For March 5, 2026

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
Earnings Scheduled For August 6, 2025

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
Earnings Scheduled For March 11, 2025

benzinga.com
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

benzinga.com
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings

benzinga.com
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day S

benzinga.com
Earnings Scheduled For March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

benzinga.com
Earnings Scheduled For November 7, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

benzinga.com
Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea